Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation

Journal of Antimicrobial Chemotherapy - Tập 59 Số 6 - Trang 1057-1064 - 2007
М. В. Афанасьев1, Larisa N. Ikryannikova1, Elena N. Ilina1, Sidorenko Sv2, Alexey V. Kuźmin3, Elena Larionova3, Tatyana Smirnova3, Л. Н. Черноусова3, E. Yu. Kamaev4, С. Н. Скорняков4, V. N. Kinsht5, А. Г. Чередниченко5, Vadim M. Govorun1
1Research Institute for Physical–Chemical Medicine of Ministry of Public Health of Russian Federation, Malaya Pirogovskaya St, 1a, 119992 Moscow, Russia
2National Research Centre for Antibiotics, Moscow, Russia
3Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russia
4Ural Research Institute for Phthisiopulmonology, Ekaterinburg, Russia
5Novosibirsk Tuberculosis Research Institute of Ministry of Public Health of Russian Federation, Novosibirsk, Russia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Federal Centre of Hygiene and Epidemiology, 2005, About Sanitary and Epidemiologic Situation in Russian Federation in 2004: Public Report

WHO, 2004, Anti-Tuberculosis Drug Resistance in the World Third Global Report

WHO, 2004, Treatment of Tuberculosis: Guidelines for National Programmes-Third Edition

Toungoussova, 2006, Epidemic of tuberculosis in the former Soviet Union: social and biological reasons, Tuberculosis (Edinb), 86, 1, 10.1016/j.tube.2005.04.001

Cheng, 2005, Molecular diagnostics in tuberculosis, Eur J Clin Microbiol Infect Dis, 24, 711, 10.1007/s10096-005-0039-1

Wade, 2004, Mechanisms of drug resistance in Mycobacterium tuberculosis, Front Biosci, 9, 975, 10.2741/1289

Ramaswamy, 1998, Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update, Tuberc Lung Dis, 79, 3, 10.1054/tuld.1998.0002

Ilina, 2005, Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping, J Clin Microbiol, 43, 2810, 10.1128/JCM.43.6.2810-2815.2005

Vereshchagin, 2005, Detection of fluoroquinolone resistance single-nucleotide polymorphisms in Neisseria gonorrhoeae gyrA and parC using MALDI-TOF mass spectrometry, Mol Biol (Mosk), 39, 806, 10.1007/s11008-005-0099-4

WHO, 1998, Laboratory Services in Tuberculosis Control Part III: Culture

A decree of the Ministry of Public Health of Russian Federation. Number 109, 2003, ‘About the Procedures of Microbiology Experiments in Treatment of Tuberculosis’

Gryadunov, 2005, Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis, Clin Microbiol Infect, 11, 531, 10.1111/j.1469-0691.2005.01183.x

Mikhailovich, 2001, Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips, J Clin Microbiol, 39, 2531, 10.1128/JCM.39.7.2531-2540.2001

Nikolayevsky, 2004, Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation, J Clin Microbiol, 42, 4498, 10.1128/JCM.42.10.4498-4502.2004

Toungoussova, 2002, Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia, J Clin Microbiol, 40, 1930, 10.1128/JCM.40.6.1930-1937.2002

Cavusoglu, 2002, Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay, J Clin Microbiol, 40, 4435, 10.1128/JCM.40.12.4435-4438.2002

Van Der Zanden, 2003, Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis, J Clin Microbiol, 41, 1101, 10.1128/JCM.41.3.1101-1108.2003

Hillemann, 2005, Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates, J Clin Microbiol, 43, 3699, 10.1128/JCM.43.8.3699-3703.2005

Shin, 2005, rpoB gene mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis in northern Lima, Peru, Microb Drug Resist, 11, 26, 10.1089/mdr.2005.11.26

Miotto, 2006, Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy, J Clin Microbiol, 44, 2485, 10.1128/JCM.00083-06

Cooksey, 1997, Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City, J Clin Microbiol, 35, 1281, 10.1128/JCM.35.5.1281-1283.1997

Jun, 2003, Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China, J Clin Microbiol, 41, 2209, 10.1128/JCM.41.5.2209-2212.2003

Zoltán, 2001, Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay, J Clin Microbiol, 39, 3736, 10.1128/JCM.39.10.3736-3739.2001

Tudo, 2004, Study of resistance to antituberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology, Int J Tuberc Lung Dis, 8, 15

Mokrousov, 2002, High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001, Antimicrob Agents Chemother, 46, 1417, 10.1128/AAC.46.5.1417-1424.2002

Taniguchi, 1996, Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis, FEMS Microbiol Lett, 144, 103, 10.1111/j.1574-6968.1996.tb08515.x